CN Patent

CN108283628B — 一种抗癌药物微囊制剂及其制备方法

Assigned to Nanjing Kang Chuan Ji Pharmatech Co ltd · Expires 2021-01-01 · 5y expired

What this patent protects

本发明属于医药制剂技术领域，涉及一种抗癌药物微囊制剂，具体涉及一种尼拉帕尼微囊制剂及其制备方法。本发明以主药尼拉帕尼和辅料硼酸为囊心物，加入聚乙烯醇制成尼拉帕尼微囊，然后将微囊和其他辅料混合均匀，制备成尼拉帕尼微囊制剂。本发明的微囊制剂载药量大，包封率好，显著地提高了尼拉帕尼的稳定性，降低了尼拉帕尼的不良反应，使药物在体内平稳释放，更好地发挥尼拉帕尼的作用，适合工业化大生产。

USPTO Abstract

本发明属于医药制剂技术领域，涉及一种抗癌药物微囊制剂，具体涉及一种尼拉帕尼微囊制剂及其制备方法。本发明以主药尼拉帕尼和辅料硼酸为囊心物，加入聚乙烯醇制成尼拉帕尼微囊，然后将微囊和其他辅料混合均匀，制备成尼拉帕尼微囊制剂。本发明的微囊制剂载药量大，包封率好，显著地提高了尼拉帕尼的稳定性，降低了尼拉帕尼的不良反应，使药物在体内平稳释放，更好地发挥尼拉帕尼的作用，适合工业化大生产。

Drugs covered by this patent

Patent Metadata

Patent number
CN108283628B
Jurisdiction
CN
Classification
—
Expires
2021-01-01
Drug substance claim
No
Drug product claim
No
Assignee
Nanjing Kang Chuan Ji Pharmatech Co ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.